Choose another country or region to see content specific to your location
United States
Choose country or region
Continue

Pharma Mar SA

Pharma Mar SA is a leading biopharmaceutical company that specializes in discovering and developing innovative marine-derived drugs to treat cancer and other diseases. With a strong focus on oncology, the company has developed a diverse portfolio of products that target various types of cancer, including lung, ovarian, and breast cancer. Its flagship product, Yondelis, is a marine-derived drug that has received approval for the treatment of soft tissue sarcoma and ovarian cancer in Europe and other countries. The company's research and development efforts are backed by a team of experienced scientists and a cutting-edge research facility. Pharma Mar SA is dedicated to enhancing the quality of life for patients by creating new and effective treatments for cancer and other illnesses.

Instrument specification for Pharma Mar SA

Name
Minimum order value
Description
Maximum order value
Transaction Step
Type
Trading Hours
Contract size / 1 lot
Deposit required
Value of 1 pip
Financial leverage
Minimal step
Long swap (daily)
Short sale NO
Short swap (daily)
Distance SL and TP 0
3-day swap (date)

Start trading now with fast account opening.

Sign-up now to trade the most active markets

Open account
Boasting over 20 years in the markets, leading analysis tools and thousands of satisfied clients, OANDA is proud to be an award-winning broker.
Get access to the most active of global markets with thousands of trading instruments at your fingertips, as well leading technical tools to assist in your analysis.
Trade without unnecessary costs and total pricing transparency - OANDA offers zero-commission on major instruments, transparent pricing.
Scroll to top